Data facts:
β’ Opening of economy and there is uplift now from corona
β’ Market shares of company has increase 2.35. Currently at 17.5% market share.
β’ Market share of group and overall business was 24.4%.
β’ Market share product was ULIP at 30%, non Par at 37% and PAr at 33%
Data facts
β’ Policy sold over 4 lacs
β’ New margin business has seen good growth
β’ Main focus now is to control cost.
β’ 48 crores set for provision of Corona, and there is no need for additional provision issue.
Cases from COVID:
β’ 418 individual case and 28 company based case
β’ 45 day waiting period for Corona as per IRDA guidelines.
β’ 10 lac per customer is brought on average for per customer.
Solvency ratio:
β’ 203% solvency ratio increased with 198% last year. This was mainly because decrease insolvency to 180% during march.
β’ Newer agent partner increased as per the target
β’ New partnership with banks: Balance partnership with Yes bank for distribution network
Technology
β’ Video based sales enablement for distribution network.
β’ This has seen good growth in tier 2 and tier 3 cities
Digital + human interaction(WeServe) solving query via video call
β’ Strong growth 11% from bank assurance sector.
β’ Company still under doldrums and don't want to be hell bound on stating double digit growth.
β’ Strong product mix is the main focus of the company
β’ Economic variance reduced, because of downward slope of yield curve.
Products Segment:
β’ ULIP assumption were tighten. Due to ULIP target was missed, however there has been good recovery and coming to target of pre-covid levels. ULIP growth is going down.
β’ Bank assurance sector has done well for par and non part segment.
β’ Par segment is going good.
However, company is looking all the 3 classification on holistic basis, whichever goes up remain main focus is to grow the business.
β’ New products are launched which can give flexibility with the claims assumed by actuarial.
β’ Market share in hdfc bank is 65-70% and company is constantly increasing its share in the HDFC bank.
β’ LP remain continue to grow
Focus:
β’ First to improve partner channels
β’ Focus on integrating digital improvement with partners
β’ Increase the partner other than HDFC
β’ Credit product margins and annuity products are continue to grow well.
β’ Persistence ratio
Company is able to reach out customers for the premium collection driving this ratio
Online has been around growing 14%, and Q2 was muted than Q1.
Reason: Google searches were high, however not all the customer turned up buying the policy.
β’ Savings of customer is going up, resulted in lower claims for insurance . However company sees this issue to be short term
There can been trend downward for the coming period, however on a longer note there will be good growth on longer period.
Risk underwriting:
β’ Company has dynamic underwriting parameters and they keep changing it with the respective factors.
Non Hdfc bank growth
β’ HDFC bank has grown well. Agency channel has seen 6% growth. However same growth was not in the coming quarter. This was mainly because of base effect, which will be out looked in future periods
β’ Bandhan, PNB banks has been growth driver, not as expected
β’ Some of the banker partners is going to pre-covid levels and some are still settling with pressure.
Marketing strategy: Campaign on term and annuity is carried and branding activity on both tier 2 and tier 3 is growing in order to grab the untap market
Products demand after COVID:
β’ First realization is going on health, and then on Life. These are high consumer products
β’ Next demand comes from ULIP which takes time.
Next focus is how to reach to customer: Company is considering technology shift more on this
β’ Agency growth: This was due to last capability program, transferring offline branch to online and other digitization with training.
β’ Operating Return on EV reducing: This was because of unwind and reduction of interest rate in the past few years has been the reason
β’ β’ β’
Missing some Tweet in this thread? You can try to
force a refresh
-Company facing problems due to Covid
-Granules has achieved the highest numbers in the history of growth story.
-PAT growth of 20% after 2021 with base of 2021.
-ROCE increased due to better utilization of plants.
-Out of approved ANDAs 6 are yet to be launched.
- PAT growth is higher than revenue growth: Due to good product mix, price realization
- Vizag facility is expected to come up next year
- Intentionally delayed launched of some products due to COVID
- Supply chain remain the continuous focus of the company
Updates on Industry:
β’ Ravi season is expected to be good.
β’ Agriculture sector is expected to deliver good growth in the coming months due to good rainfall
β’ Pesticides and Insecticides use was less in the coming quarter.
β’ 3 key products show good growth
β’ Prioritizing cash flow result to increase in cash flow
β’ Main focus remain to bring new and innovative product
New product:
β’ Launched 1 formulation product, and gradual pick up in sales
β’ 2 new crop nutrition product
Β€ SIP is defined as a method of investing a certain amount periodically. It is one of the methods of investing in a mutual fund. Don't be misled by the fact that mutual funds are all about SIP.
Β€ Strong focus over SIP has led people to change their investment style, ignoring the impact on their returns. When there is a sharp correction in the market, it is much advisable to invest in a lump-sum.
1/ In 1886, May 8, John Pemberton used coca leaves, sugar, and cola nuts to prepare his syrup. The product was first sold as a medicinal beverage in Jacob's pharmacy in Atlanta for 5 cents a glass for diseases including nerve disorders, headaches, indigestion & morphine addiction
2/ It was John Pemberton's bookkeeper, Frank M. Robinson, who gave the syrup the official name as Coca-Cola, including the logo too. Pemberton had left it to Robinson to promote the product of his own.